KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Interest & Investment Income (2022 - 2023)

AbCellera Biologics (ABCL) has disclosed Interest & Investment Income for 2 consecutive years, with $11.0 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Interest & Investment Income rose 29.9% year-over-year to $11.0 million, compared with a TTM value of $42.2 million through Dec 2023, up 162.75%, and an annual FY2024 reading of $38.5 million, down 8.93% over the prior year.
  • Interest & Investment Income was $11.0 million for Q4 2023 at AbCellera Biologics, up from $10.7 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $11.0 million in Q4 2023 and bottomed at $665000.0 in Q1 2022.